Polyamine blockade promotes antitumor immunity

Por Hayes, Candace S, Burns, Mark R, Gilmour, Susan K
Publicado em 2014

Structure-Activity Relationships of Antimicrobial and Lipoteichoic Acid-Sequestering Properties in Polyamine Sulfonamides

Por Warshakoon, Hemamali J., Burns, Mark R., David, Sunil A.
Publicado em 2009

Lipophilic Lysine-Spermine Conjugates are Potent Polyamine Transport Inhibitors for use in Combination with a Polyamine Biosynthesis Inhibitor

Por Burns, Mark R., Graminski, Gerard F., Weeks, Reitha S., Chen, Yan, O’Brien, Thomas G.
Publicado em 2009

Phase I/II clinical trial of 2-Difluoromethylornithine (DFMO) and a novel polyamine transport inhibitor (MQT 1426) for feline oral squamous cell carcinoma

Por Skorupski, Katherine A., O'Brien, Thomas G., Guerrero, Teri, Rodriguez, Carlos O., Burns, Mark R.
Publicado em 2011

Polyamine-Blocking Therapy Reverses Immunosuppression in the Tumor Microenvironment

Por Hayes, Candace S., Shicora, Allyson C., Keough, Martin P., Snook, Adam E., Burns, Mark R., Gilmour, Susan K.
Publicado em 2013

Structural Correlation Between Lipophilicity and Lipopolysaccharide-sequestering activity in Spermine-Sulfonamide Analogs

Por Burns, Mark R., Jenkins, Scott A., Vermeulen, Nicolas M., Balakrishna, Rajalakshmi, Nguyen, Thuan B., Kimbrell, Matthew R., David, Sunil A.
Publicado em 2006